Views & Analysis Clinical trials: realising the untapped potential Winning proposal to create a corporate social responsibility (CSR) programme.
Articles Clinical trials insight: oncology INC Research's Dr Nick Kenny talks about the challenges of running global clinical trials in the rapidly evolving field of oncology.
News Nuvalent chases after Nuvation in ROS1 lung cancer New trial data sets up a filing for Nuvalent's new-generation ROS1 inhibitor in NSCLC, although it has an uphill battle to catch rival Nuvation.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
